Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-11-18
1982-09-14
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
2601125R, 424177, 424180, 536 27, 536 28, 536 29, A61K 4502, A61K 3702, C07C10352
Patent
active
043495389
ABSTRACT:
A nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid, poly-1-lysine, and carboxymethylcellulose, and injectable preparations thereof in a pharmaceutically acceptable aqueous carrier such as saline solution. When administered to a human or non-human primate host, the complex is effective in inducing the synthesis in such host of antiviral levels of interferon.
REFERENCES:
patent: 4024241 (1977-05-01), Levy
Chemical Abstracts, vol. 92, Abstract No. 174365n, p. 37, 1980.
Chemical Abstracts, vol. 92, Abstract No. 104368s, p. 57, 1980.
Chemical Abstracts, vol. 93, Abstract No. 197823v, p. 61, 1980.
Chemical Abstracts, vol. 91, Abstract No. 321y, p. 319 1979.
Chemical Abstracts, vol. 92, Abstract No. 600v, p. 596, 1980.
Derwent Abstracts, Belgium Pat. No. 833838, 1976.
Hazel Blondel
The United States of America as represented by the Secretary of
LandOfFree
Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclease-resistant hydrophilic complex of polyriboinosinic-polyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2154757